Skip to content

13F-HR filed by Sio Capital Management, LLC

Sio Capital Management, LLC filed this 13F-HR for the quarter ended 2017-09-30, filed 2017-11-14, with 54 holding rows worth $192,727,000.

Accession
0001214659-17-006698
Filed
2017-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2017

A holdings report, 54 entries on the cover page, a total value of $192,727,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $192,727,000 with VALUE read as thousands by filing date, 13F file number 028-13691. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
AXOVANT SCIENCES LTDG0750W104COM3,638,700$25,034,000thousands by filing dateput
SAGE THERAPEUTICS INC78667J108COM190,400$11,862,000thousands by filing dateput
QUOTIENT LTDG73268107SHS2,344,311$11,557,000thousands by filing date
ADAMIS PHARMACEUTICALS CORP00547W208COM NEW1,935,961$10,115,000thousands by filing date
INSMED INC COM PAR $.01457669307Stock266,800$8,327,000thousands by filing dateput
AETNA INC NEW00817Y108COM50,523$8,034,000thousands by filing date
AXOVANT SCIENCES LTDG0750W104COM1,118,894$7,698,000thousands by filing date
GLAXOSMITHKLINE PLC-ADR37733W105SPONSORED ADR171,694$6,971,000thousands by filing date
AGIOS PHARMACEUTICALS INC00847X104COM83,100$5,547,000thousands by filing dateput
SEATTLE GENETICS INC812578102COM100,000$5,441,000thousands by filing dateput
BIOGEN INC COM09062X103Stock15,549$4,869,000thousands by filing date
GLOBUS MED INC CL A379577208Stock147,364$4,380,000thousands by filing date
Medtronic PlcG5960L103COM55,844$4,343,000thousands by filing date
KURA ONCOLOGY INC COM50127T109Stock275,731$4,122,000thousands by filing date
GLAXOSMITHKLINE PLC-ADR37733W105SPONSORED ADR100,000$4,060,000thousands by filing datecall
RIGEL PHARMACEUTICALS INC766559603COMMON STOCK1,563,307$3,971,000thousands by filing date
HALYARD HEALTH INC40650V100COM86,914$3,914,000thousands by filing date
EAGLE PHARMACEUTICALS INC269796108COM63,835$3,807,000thousands by filing date
EMERGENT BIOSOLUTIONS INC29089Q105COM90,268$3,651,000thousands by filing date
ZIMMER BIOMET HOLDINGS INC COM98956P102Stock31,033$3,634,000thousands by filing date
ADVANCED ACCELERATOR APPLIC SPONSORED ADS00790T100ADR52,582$3,556,000thousands by filing date
PUMA BIOTECHNOLOGY INC74587V107COMMON STOCK27,221$3,260,000thousands by filing date
ZOETIS INC CL A98978V103Stock50,000$3,188,000thousands by filing dateput
KONINKLIJKE PHILIPS N V NY REGIS SHS NEW500472303ADR67,829$2,795,000thousands by filing date
ICON PUB LTD CO SHSG4705A100Stock23,604$2,688,000thousands by filing date
INTEGER HLDGS CORP45826H109COM51,258$2,622,000thousands by filing date
Intuitive Surgical,Inc.46120E602COM2,500$2,615,000thousands by filing dateput
Elevance Health, Inc.036752103COM13,418$2,548,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock20,225$2,376,000thousands by filing date
LUMINEX CORP55027E102COMMON STOCK115,979$2,358,000thousands by filing date
Vertex Pharmaceuticals Incorporated92532F100COM14,874$2,261,000thousands by filing date
SANOFI SA SPONSORED ADR80105N105ADR45,099$2,245,000thousands by filing date
UnitedHealth Group Inc91324P102COM11,430$2,239,000thousands by filing date
CATALYST BIOSCIENCES INC14888D208COM421,635$2,133,000thousands by filing date
ARENA PHARMACEUTICALS INC040047607COM NEW72,086$1,838,000thousands by filing date
VOCERA COMMUNICATIONS INC92857F107COMMON STOCK56,106$1,760,000thousands by filing date
EVOLENT HEALTH INC CL A30050B101Stock78,600$1,399,000thousands by filing date
MADRIGAL PHARMACEUTICALS INC COM558868105Stock26,958$1,213,000thousands by filing date
AVADEL PHARMACEUTICALS, PLC05337M104COMMON STOCK-FO91,413$960,000thousands by filing date
ACTINIUM PHARMACEUTICALS INC00507W107COM1,590,267$915,000thousands by filing date
FOAMIX PHARMACEUTICALS LTDM46135105SHS139,200$773,000thousands by filing date
DBV TECHNOLOGIES S A23306J101ADR18,200$772,000thousands by filing dateput
XENCOR INC98401F105COMMON STOCK33,100$759,000thousands by filing date
ACADIA HEALTHCARE COMPANY INC COM00404A109Stock13,800$659,000thousands by filing dateput
PROGENICS PHARMACEUTICALS IN743187106COM88,523$652,000thousands by filing date
AEGLEA BIOTHERAPEUTICS INC00773J103COM129,583$639,000thousands by filing date
CYMABAY THERAPEUTICS INC23257D103COM75,000$605,000thousands by filing date
OTONOMY INC68906L105COM100,900$328,000thousands by filing date
OTONOMY INC68906L105COM100,900$328,000thousands by filing dateput
PFENEX INC717071104COM85,867$259,000thousands by filing date
OASMIA PHARMACEUTICAL AB67421W109ADR203,170$211,000thousands by filing date
CHEMOCENTRYX INC16383L106COM25,182$187,000thousands by filing date
STEADYMED LTDM84920103SHS54,950$184,000thousands by filing date
SUNESIS PHARMACEUTICALS INC867328700COM33,710$65,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001214659-17-006698this filing2017-11-14acceptance time not in the bulk data set